← Back to Search

Cystic fibrosis patients for Cystic Fibrosis

N/A
Waitlist Available
Led By Amanda Dye, MD
Research Sponsored by CAMC Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in pulmonary function status
Morphological variable changes
Resting energy expenditure estimation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cystic fibrosis patientsExperimental Treatment1 Intervention
Patients with cystic fibrosis who are six year or older, who regularly receive care at the West Virginia University-Charleston Cystic Fibrosis Center, and agreed to participate in the study.

Find a Location

Who is running the clinical trial?

CAMC Health SystemLead Sponsor
45 Previous Clinical Trials
7,986 Total Patients Enrolled
Amanda Dye, MDPrincipal Investigator - CAMC and WVU-Charleston
Charleston Area Medical Center-Women's & Children's Hospital
West Virginia University School Of Medicine (Medical School)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025